A 28-year-old woman with a history of penicillin allergy (non-anaphylactic rash) presents with orbital cellulitis secondary to ethmoid sinusitis. Which antibiotic regimen is most appropriate for her?

Explanation

## Orbital Cellulitis in Penicillin-Allergic Patients ### Allergy Classification & Cross-Reactivity **Key Point:** A non-anaphylactic penicillin allergy (e.g., rash, mild GI upset) carries a **<3% cross-reactivity risk** with third-generation cephalosporins (ceftriaxone, cefotaxime). Cephalosporins are safe and preferred in non-IgE-mediated penicillin allergy. **Warning:** Only true IgE-mediated anaphylaxis to penicillin (anaphylaxis, angioedema, Stevens-Johnson syndrome) warrants absolute avoidance of cephalosporins; even then, third-generation agents are safer than first-generation. ### Why Ceftriaxone + Vancomycin Remains First-Line In this patient with a **non-anaphylactic** penicillin allergy: - **Ceftriaxone** is safe and provides optimal gram-negative and sensitive gram-positive coverage - **Vancomycin** covers MRSA and resistant gram-positive organisms - This combination remains superior to alternatives for orbital cellulitis ### Alternative Regimens (if true anaphylaxis) If the patient had documented **anaphylaxis** to penicillin, alternatives would include: - **Fluoroquinolone (levofloxacin or moxifloxacin) + Clindamycin** — acceptable but less ideal (fluoroquinolone monotherapy is insufficient for gram-positive coverage) - **Chloramphenicol** — rarely used today due to bone marrow toxicity and lack of MRSA coverage ### Dosing for This Patient | Drug | Dose | Frequency | |------|------|----------| | Ceftriaxone | 1–2 g | IV every 12 hours | | Vancomycin | 15–20 mg/kg | IV every 8–12 hours | **Clinical Pearl:** Always document the **type and timing** of penicillin reaction. Non-anaphylactic rashes (delayed, maculopapular) do not preclude use of cephalosporins; anaphylaxis mandates alternatives. **High-Yield:** The distinction between anaphylactic and non-anaphylactic penicillin allergy is critical in orbital cellulitis management—it determines whether cephalosporins are safe to use. [cite:Orbit and Ocular Adnexa, Ophthalmology textbooks; Harrison's Ch 376]